COAGULOPATHY ASSOCIATED WITH AIDS, ARC AND KAPOSI'S SARCOMA: IMPLICATIONS FOR A NEW CONCEPT OF PATHOGENESIS, DIAGNOSIS AND TREATMENT (MEETING ABSTRACT)

Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

COAGULOPATHY ASSOCIATED WITH AIDS, ARC AND KAPOSI'S SARCOMA: IMPLICATIONS FOR A NEW CONCEPT OF PATHOGENESIS, DIAGNOSIS AND TREATMENT (MEETING ABSTRACT)

Proc Annu Meet Am Soc Clin Oncol; 10:A8 1991. Unique Identifier : AIDSLINE ICDB/91671490
Samuels A; Century of Life Inst., Los Angeles, CA 90048

Abstract: In a previous report (6th International Conference on Adjuvant Therapy of Cancer, Tucson, AZ, 3/7-10/90), an example of benefit from the simultaneous adjuvant treatment of a hypercoagulable state, and fibrinolytic failure in a 75-yr-old female with 'terminal' disseminated malignant disease (Ca breast) and deep vein thrombosis (DVT) by prolonged iv heparin therapy was described. Her complete remission is now in its 4th yr. Because a similar result has been observed in a 70-yr-old male with disseminated Kaposi's sarcoma (DKS), DVT and coagulopathy, the results of studies in 3 pts with AIDS, and in 1 pt with ARC are presented in a table, and compared with the data previously reported. All show a similar coagulopathy. These results suggest that effective adjuvant treatment of an associated coagulopathy might be of benefit in the therapeutic management of DKS, AIDS and ARC.

Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/DIAGNOSIS/ PATHOLOGY/*PHYSIOPATHOLOGY Aged AIDS-Related Complex/COMPLICATIONS/DIAGNOSIS/PATHOLOGY/ *PHYSIOPATHOLOGY Blood Coagulation Disorders/ETIOLOGY/*THERAPY Breast Neoplasms/COMPLICATIONS/PHYSIOPATHOLOGY Case Report Female Heparin/ADMINISTRATION & DOSAGE/*THERAPEUTIC USE Human Infusions, Intravenous Male Sarcoma, Kaposi's/COMPLICATIONS/DIAGNOSIS/PATHOLOGY/ *PHYSIOPATHOLOGY Thrombophlebitis/COMPLICATIONS/THERAPY ABSTRACT
910930
M9190740

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .